TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer

[Source: TGen] - Researchers for TGen Clinical Research Services at Scottsdale Healthcare (TCRS) have identified a way to predict which patients with small-cell lung cancer may be resistant to first-line chemotherapy.

The study, Tumor MicroRNA Biomarkers Associated with De Novo Chemoresistance in Small Cell Lung Cancer, will be presented today in San Diego at a joint conference of the American Association for Cancer Research (AACR) and the International Association for the Study of Lung Cancer (IASLC).

This breakthrough is critical since patients with small-cell lung cancer (SCLC) often do not get a second chance at therapies to combat this aggressive type of cancer.

For more information: TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer

Scottsdale Healthcare is world’s first site to test new drug

[Source: Scottsdale Healthcare] - TGen Clinical Research Services at Scottsdale Healthcare (TCRS) is the world’s first clinical trials site for a new drug designed to halt cancer cell division.

NMS-1286937 is produced by Nerviano Medical Sciences of Milan, Italy’s largest pharmaceutical research and development facility. NMS-1286937 is designed to stop cancer from spreading by preventing mitosis, the process of cell division.

For more information: Scottsdale Healthcare is world’s first site to test new drug by major Italian pharmaceutical firm

Cancer Treatment Centers of America growing, still hiring

[Source: The Arizona Republic] - Cancer Treatment Centers of America says it's growing and hiring in line with projections as it approaches its first anniversary.

When the national hospital chain opened its Western Regional Medical Center in late 2008, the company anticipated having 400 employees within two to four years.

For more information: Cancer Treatment Centers of America growing, still hiring